Differential PKA activation and AKAP association determines cell fate in cancer cells

Journal of Molecular Signaling

Volumn 8, Issue , 2013, Pages

  Hedrick, Erik D ^a   Agarwal, Ekta ^a   Leiphrakpam, Premila D ^a   Haferbier, Katie L ^a   Brattain, Michael G ^a   Chowdhury, Sanjib ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

AKAP149; Colorectal cancer; IGF1R; PKA; Praja2; XIAP

Indexed keywords

CASPASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; SOMATOMEDIN RECEPTOR; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; APOPTOSIS; ARTICLE; CAMP ASSAY; CANCER CELL; CELL CULTURE; CELL DEATH; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TGF BETA SIGNALING; WESTERN BLOTTING;

EID: 84884959434     PISSN: None     EISSN: 17502187     Source Type: Journal    
DOI: 10.1186/1750-2187-8-10     Document Type: Article

References (37)

1. Rodon J, DeSantos V, Ferry RJ Jr, Kurzrock R: Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials. Mol Cancer Ther 2008, 7(9):2575-2588
2. Ryan PD, Goss PE: The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist 2008, 13(1):16-24
3. Valentinis B, Baserga R: IGF-I receptor signalling in transformation and differentiation. Mol Pathol 2001, 54(3):133-137
4. Buck E, Gokhale PC, Koujak S, Brown E, Eyzaguirre A, Tao N, Rosenfeld-Franklin M, Lerner L, Chiu MI, Wild R, et al: Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF1R and IR in cancer. Mol Cancer Ther 2010, 9(10):2652-2664
5. Godsland IF: Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) 2009, 118(5):315-332
6. Weber MM, Fottner C, Liu SB, Jung MC, Engelhardt D, Baretton GB: Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Cancer 2002, 95(10):2086-2095
7. Mulvihill MJ, Cooke A, Rosenfeld-Franklin M, Buck E, Foreman K, Landfair D, O'Connor M, Pirritt C, Sun Y, Yao Y, et al: Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor. Future Med Chem 2009, 1(6):1153-1171
8. Pitts TM, Tan AC, Kulikowski GN, Tentler JJ, Brown AM, Flanigan SA, Leong S, Coldren CD, Hirsch FR, Varella-Garcia M, et al: Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early development. Clin Cancer Res 2010, 16(12):3193-3204
9. Chowdhury S, Howell GM, Rajput A, Teggart CA, Brattain LE, Weber HR, Chowdhury A, Brattain MG: Identification of a novel TGFbeta/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer. PLoS One 2011, 6(5):e19335
10. Dubrez-Daloz L, Dupoux A, Cartier J: IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 2008, 7(8):1036-1046
11. Dohi T, Xia F, Altieri DC: Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell 2007, 27(1):17-28
12. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC: IAP regulation of metastasis. Cancer Cell 2010, 17(1):53-64
13. Chowdhury S, Howell GM, Teggart CA, Chowdhury A, Person JJ, Bowers DM, Brattain MG: Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death. J Biol Chem 2011, 286(35):30937-30948
14. Agarwal E, Brattain MG, Chowdhury S: Cell survival and metastasis regulation by Akt signaling in colorectal cancer. Cell Signal 2013, 25(8):1711-1719
15. Pidoux G, Tasken K: Specificity and spatial dynamics of protein kinase A signaling organized by A-kinase-anchoring proteins. J Mol Endocrinol 2010, 44(5):271-284
16. Welch EJ, Jones BW, Scott JD: Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 2010, 10(2):86-97
17. Lignitto L, Carlucci A, Sepe M, Stefan E, Cuomo O, Nistico R, Scorziello A, Savoia C, Garbi C, Annunziato L, et al: Control of PKA stability and signalling by the RING ligase praja2. Nat Cell Biol 2011, 13(4):412-422
18. Zhang L, Duan CJ, Binkley C, Li G, Uhler MD, Logsdon CD, Simeone DM: A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A. Mol Cell Biol 2004, 24(5):2169-2180
19. Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG: Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Res 2008, 68(9):3152-3160
20. Donovan EA, Kummar S: Role of insulin-like growth factor-1R system in colorectal carcinogenesis. Crit Rev Oncol Hematol 2008, 66(2):91-98
21. Schimmer AD, Dalili S: Targeting the IAP family of caspase inhibitors as an emerging therapeutic strategy. Hematology Am Soc Hematol Educ Program 2005:215-219
22. Schimmer AD, Dalili S, Batey RA, Riedl SJ: Targeting XIAP for the treatment of malignancy. Cell Death Differ 2006, 13(2):179-188
23. Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, et al: The role of transforming growth factor alpha in determining growth factor independence. Cancer Res 2003, 63(15):4731-4738
24. Boyd DD, Levine AE, Brattain DE, McKnight MK, Brattain MG: Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose. Cancer Res 1988, 48(9):2469-2474
25. Hu YP, Patil SB, Panasiewicz M, Li W, Hauser J, Humphrey LE, Brattain MG: Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Res 2008, 68(19):8004-8013
26. Jiang D, Yang H, Willson JK, Liang J, Humphrey LE, Zborowska E, Wang D, Foster J, Fan R, Brattain MG: Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states. J Biol Chem 1998, 273(47):31471-31479
27. Wang D, Li W, Jiang W, Humphrey LE, Howell GM, Brattain MG: Autocrine TGFalpha expression in the regulation of initiation of human colon carcinoma growth. J Cell Physiol 1998, 177(3):387-395
28. Andersen MH, Svane IM, Becker JC, Straten PT: The universal character of the tumor-associated antigen survivin. Clin Cancer Res 2007, 13(20):5991-5994
29. Eckelman BP, Salvesen GS, Scott FL: Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 2006, 7(10):988-994
30. Fabregat I: Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol 2009, 15(5):513-520
31. Almeida MQ, Stratakis CA: How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues? Mol Cell Endocrinol 2011, 336(1-2):162-168
32. Brattain MG, Levine AE, Chakrabarty S, Yeoman LC, Willson JK, Long B: Heterogeneity of human colon carcinoma. Cancer Metastasis Rev 1984, 3(3):177-191
33. Brattain MG, Marks ME, McCombs J, Finely W, Brattain DE: Characterization of human colon carcinoma cell lines isolated from a single primary tumour. Br J Cancer 1983, 47(3):373-381
34. Chowdhury S, Ongchin M, Sharratt E, Dominguez I, Wang J, Brattain MG, Rajput A: Intra-Tumoral Heterogeneity in Metastatic Potential and Survival Signaling between Iso-Clonal HCT116 and HCT116b Human Colon Carcinoma Cell Lines. PLoS One 2013, 8(4):e60299
35. Chowdhury S, Ongchin M, Wan G, Sharratt E, Brattain MG, Rajput A: Restoration of PTEN activity decreases metastases in an orthotopic model of colon cancer. J Surg Res 2013, 184(2):755-760
36. Chowdhury S, Sharratt E, Spernyak J, Brattain MG, Rajput A: Anti-tumor activity of IGF1R kinase inhibitor PQIP in colon cancer. Clin Exp Pharmacol 2013, S4:005
37. Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, Huang DC, Bouillet P, Thomas HE, Borner C, Silke J, et al: XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 2009, 460(7258):1035-1039